| 2-Pyrrolidinecarbonitrile, 4-fluoro-1-[2-[(2-hydroxy-1,1-dimethylethyl)amino]acetyl]-, (2S,4S)- |
625110-37-4 |
625110-37-4 |
| GSK-LSD1 Dihydrochloride |
2102933-95-7 |
2102933-95-7 |
| MK181 |
化合物 T28054 |
314297-32-0 |
| 4SC-207 |
4SC-207 |
871015-11-1 |
| t-Boc-N-Amido-PEG2-Propargyl |
t-Boc-N-Amido-PEG2-Propargyl |
869310-84-9 |
| (2S)-N-[(1R)-1-[4-(2,4-dimethoxyphenyl)-5-(3-ethylindol-1-yl)-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyrrolidine-2-carboxamide |
JMV3008 , CID74015851 |
925239-09-4 |
| (R)-(+)-8-methyl-5-(3-methyl-4-nitrophenyl)-8,9-dihydro-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepine |
(R)-(+)-8-METHYL-5-(3-METHYL-4-NITROPHENYL)-8,9-DIHYDRO-7H-1,3-DIOXOLO[4,5-H][2,3]BENZODIAZEPINE |
732277-05-3 |
| CD73-IN-1 |
2132396-40-6 |
2132396-40-6 |
| Cdk1/2 Inhibitor III |
Cdk1/2 Inhibitor III |
443798-47-8 |
| Cyclo(L-Phe-L-Val) |
(3S,6S)-3-苄基-6-异丙基哌嗪-2,5-二酮 |
35590-86-4 |
| BI-3812 |
CPD1815 |
2166387-64-8 |
| GLP-1 receptor agonist-1 |
2230197-64-3 |
2230197-64-3 |
| GENZ-882706(Raceme) |
2070861-46-8 |
2070861-46-8 |
| AGN 194078 |
321995-62-4 |
321995-62-4 |
| (R)-ADX-47273 |
851881-59-9 |
851881-59-9 |
| 3-(4-Bromophenyl)-7-[(methylsulfonyl)oxy]-4-oxo-4H-chromene |
3-(4-溴苯基)-4-氧代-7-[(甲磺酰基)氧基]-4H-色烯 |
610753-87-2 |
| Staphyloccocus UPPS Inhibitor methanesulfonate |
Staphyloccocus UPPS Inhibitor methanesulfonate |
801985-13-7 |
| PXS-5153A |
PXS-5153A |
2125956-82-1 |
| Rifalogue |
RIFALOGUE |
845625-44-7 |
| Fructoheptasaccharide |
蔗果七塘 |
62512-20-3 |
QQ
微信
